About Okami
Okami Medical, Inc. is a privately-held medical device company with a mission to address the evolving needs of patients and physicians through the development of innovative, versatile, and intuitive devices for the occlusion of peripheral vessels. Okami designed the LOBO® Vascular Occlusion System to allow physicians to access and rapidly occlude a wide range of vascular targets. The company was created in 2017 by Inceptus Medical, a medical device incubator. Okami is backed by members of the board of directors, Vensana Capital, U.S. Venture Partners (USVP), and other medical device industry veterans.
Management Team
Drew Hykes
President & Chief Executive Officer
Drew is a proven medical device operating executive with broad functional, geographic and sector experience. Prior to joining Okami, Drew served as CEO of Inari Medical from 2023 until its acquisition by Stryker Corporation in 2025 for $5 billion. From 2020-2022, Drew was Chief Operating Officer of Inari Medical leading its day-to-day business operations. From 2017-2019 he served as Inari’s Chief Commercial Officer.
Prior to Inari, from 2012-2016 Drew served as the VP of Commercial Operations at Sequent Medical where he led the commercialization strategy for the WEB Aneurysm Embolization system from early prototype to broad adoption in the European market. Sequent was acquired by Terumo Corporation in July 2016 for $380 million. Prior to Sequent, Drew spent 11 years at Medtronic. His roles at Medtronic included the VP of Marketing for the AF Solutions business, VP of Clinical and Regulatory for the AF Solutions business and Director of Investor Relations. Drew also spent three years on an expatriate assignment in Europe leading the launch of Medtronic’s first drug eluting coronary stent. Prior to Medtronic, he spent four years at ABN AMRO bank in Chicago focused on healthcare transactions.
He holds a B.B.A. in Finance from the University of Wisconsin and an MBA from Harvard Business School.
Terry Hardin
Vice President of Research & Development and Clinical
Terry has broad functional experience in the medical device space with a focus on early stage companies. Prior to Okami, he served as Vice President of Technology and Product Management at Cianna Medical, which developed and commercialized the SCOUT Radar Surgical Guidance System. The company was acquired by Merit Medical for $200M. Terry held additional roles at Cianna Medical in marketing, product management and sales. Prior to Cianna, Terry was a Product Development Engineer at Suros Surgical Systems, helping to develop an innovative product line that led to a $240M acquisition by Hologic. Terry earned his B.S. in Chemical Engineering and M.S. in Biomedical Engineering from Rose-Hulman Institute of Technology. He is an inventor on over 15 issued U.S. and international patents.
Steve Kain
Vice President of Strategy, Finance, and Commercial Operations
Steve joined Okami Medical as the Vice President of Marketing and Commercial Operations in May of 2024. Before Okami, Steve spent 2 years consulting for several start-up and early-stage commercial medical device organizations. Prior to consulting, Steve was at Cardiovascular Systems, Inc. where he served as the Vice President of Marketing and Commercial Operations, responsible for leading the marketing, portfolio strategy, commercial operations, and health economics and reimbursement functions. Throughout his career at both Cardiovascular Systems and previously at Medtronic, Steve held several leadership roles in international, strategy, marketing, finance, and business development. Steve graduated with a B.A. Degree from Luther College and an M.B.A. from the Carlson School of Business, at the University of Minnesota.
Eric Louw
Vice President of Operations
Eric brings over 23 years of medical device manufacturing experience. During this time Eric has held positions at all levels of manufacturing operations including production, production support, engineering, and management. Eric has a passion for medical device manufacturing and possesses a strong skillset for rapidly scaling production operations while maintaining the highest level of product quality. Eric has extensive experience in the successful transition of new products into high volume manufacturing, as well as establishing and maintaining a robust product supply chain. Prior to Okami, from 2014 – 2025, Eric held roles of increasing responsibility at Inari Medical, including Vice President of Manufacturing. Inari was acquired by Stryker in 2025. Prior to Inari, Eric held engineering positions of increasing responsibility at SenoRx Inc, as well as Bard Peripheral Vascular who acquired SenoRx in 2010.
Brett Vollert
Vice President of Marketing
Brett joins Okami Medical as Vice President of Marketing with over a decade of experience in medical device commercialization and innovation. Brett has played a key role in launching and scaling breakthrough therapies that improve patient outcomes and redefine standards of care. Prior to Okami, Brett held multiple marketing leadership roles at Inari Medical, where he helped drive rapid growth and establish the company as a leader in venous and arterial therapies. Most recently, Brett led the marketing team for the LimFlow business unit of Inari Medical, which was their first acquisition and expansion into transformative therapies for CLTI patients. Prior to Inari, Brett held sales roles at Stryker Orthopedics and Medtronic and worked in chemical analysis at Baxter Bioscience. Brett holds a Bachelor of Science from the University of Oregon.
Board of Directors
Drew Hykes
President & Chief Executive Officer
Bill Hoffman
Chairman of the Board
Bob Rosenbluth, Ph.D.
Co-Founder & Board Member
Mike Kramer
Board Member
Kirk Nielsen
Board Member
Jonathan Root, M.D.
Board Member
Donald Milder
Board Member
Geoff Pardo
Board Member
Susana Amorim
Board Member